Avadel Pharmaceuticals Public Limited Company operates as specialty pharmaceutical company. The Company develops a medicines for chronic urological, central nervous system, and sleep disorders. Avadel Pharmaceuticals serves hospitals worldwide.

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Avadel Pharmaceuticals PLC (AVDL US)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-30)

Current Report (Form 8-K | Period ending 2024-10-17)

Current Report (Form 8-K | Period ending 2024-09-12)

Current Report (Form 8-K | Period ending 2024-08-27)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)